George Scangos and Biogen Comeback

December 5, 2012 | Two years in, George Scangos is leading leads Biogen Idec's comeback story. He's cut costs and jobs and moved away from cancer research, but has invested in neuroscience and hemophilia and raised sales 19% and net income 27%. Forbes